Integrated Research shares on watch following major contract renewal

The Integrated Research Limited (ASX: IRI) share price will be on watch for the remainder of the day after announcing a contract renewal.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Integrated Research Limited (ASX: IRI) share price will be on watch for the remainder of the day after the company announced the renewal and extension of a major client software agreement.

At the time of writing, Integrated Research shares were down by 1.8% on a day which has seen the S&P/ASX 200 Index (ASX: XJO) fall sharply so far by 3.2%.

Integrated Research is a provider of performance management software for critical IT infrastructure, payments and unified communications.

Over the past 12 months, the Integrated Research share price has risen by 12% and while the ASX 200 Index has lost over 20% in the current crash, Integrated Research has been much less impacted, falling by only 6%.

Details of contract renewal with JP Morgan Chase

At around midday today, Integrated Research announced it has renewed and extended its software license agreement with JP Morgan Chase for a very sizeable total contract value of US$10 million. The tech provider added that the contract has been extended for a 5-year term and the terms of the contract encompass products in Integrated Research's Payments and Infrastructure portfolio.

For the past 25 years, JP Morgan Chase has been using Integrated Research's IR Prognosis solution in order to tap into real-time payment transaction data to support its core business decisions.

Integrated Research commented that one of the key reasons behind JP Morgan's decision to renew were the recent innovations and enhancements that Integrated Research made to its current 11.7 version IR Prognosis product.

Commenting on today's announcement, John Ruthven, Chief Executive Officer of Integrated Research said, "This contract is further validation of the mission critical nature of IR solutions with major enterprises."

Recap of recent financial result announcement

As announced last month, Integrated Research achieved a 1% increase in profit after tax to $11.8 million for its H1 FY2020 results, when compared to the prior corresponding period. Meanwhile, overall license sales increased by 7% to $33.4 million and total revenue increased by 6% to $53.2 million. However, its payments revenue declined by 14% to $7.8 million.

The company declared a fully franked interim dividend of 3.5 cents per share and noted that it has maintained a strong financial position with total cash of $7.6 million at 31 December 2019.

Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Integrated Research Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Two workers at an oil rig discuss operations.
Broker Notes

Should you buy Santos, Beach Energy or Woodside shares? Here's Macquarie's top pick

Macquarie has released its new share price expectations for Santos, Beach Energy and Woodside shares.

Read more »

A green fully charged battery symbol surrounded by green charge lights representing the surging Vulcan share price today
Share Market News

Up 300% in 6 months! This soaring ASX lithium stock just took a major step to production

Marching forward.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Share Market News

Macquarie says this top ASX tech stock could rise 15%

Let's see what the broker is saying about this stock.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »